Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I guess they are running out of shares imo. With a PR expected sometime this week as well as the 8K, BIG things could happen.
.56 is pretty much gold, nice buy!
Welcome, you may have timed this perfectly
Interestingggg, has it gotten filled yet?
Ya looking pretyyy good so far today, lets hope it continues!
Well I know CBIS is creating PTSD medication from cannabis extracts, big pharm. might have to pay them for it.
Hmm, I wonder which medical marijuana company benefits from this the most...
Just put in my vote(#886).
I could not agree with you more. Things are looking absolutely fantastic.
A/S: 250,000,000
O/S: 65,570,574
Bottom is hard to say but their current market cap is $4,262,087.31 and they are currently making more annual revenues than that, not to mention that they have an extraordinary growth rate as well. Essentially these prices are a gift imo. We should be above the .40 range in the midterm. Of course I am long and waiting for $ land down the road.
I always thought CBIS' idea to go with PTSD as their first FDA drug was brilliant. Not only will it be extremely valuable but the amount of people they will be able to help is going to be amazing. Lots of relief for lots of people! It is also a hot political topic at the moment.
I wouldn't be surprised if they PR'd about this event, they always seem to stay on top of political news when it comes to the MMJ movement. But I also think the PR he was talking about is a material event that is something CBIS has done. Maybe the financial numbers on the latest acquisition. Also look for the 8K this week!
About time we give them the medicine they deserve for their sacrifice!
It is crazy that CBIS' market cap is currently $4,225,037, when just one of our operations makes more annual revenues than that. What a steal!
That is absolutely amazing news! Thanks for posting.
Well it is also their corporate office so I doubt all the space can be used to grow cannabis, but at least we now have a corporate office. And I mean what other publicly traded company can say they grow cannabis in their corporate office, how sweet is that imo.
Welcome to the board! I'm liking what you've got to say, keep us informed as you continue your DD!
20100723|CBIS|262250|530490|O 49.44%
Just got off the phone with Mark, exciting things are happening. First of all I asked him about the 8K for Montana Pain Management and he said that it was in the works and should be out shortly. Secondly he talked about a meeting he has in California this weekend and on Tuesday with a couple investment groups. He also brought up that shorts are most likely responsible for the current share price and that they are looking more in depth into it. He also said there would be a press release next week that he couldn't talk about, but that it would be significant. The last thing we talked about was how CBIS expects to have a product on the market this fall. He didn't say much about the product other than it would be without psychoactive properties but that it would still be useful in treating certain medical ailments effectively. All good stuff imo. Oh and I am also going to be in Colorado in the next couple weeks and we talked about setting up a time for me to take photographs of the various CBIS installments in Colorado.
20100722|CBIS|209432|344311|O 60.83%
Nice summary of events.
"March 2, 1010
CBIS announced that they have the results of their survey of more than 1,300 individuals with Post Traumatic Stress Disorder (PTSD) which included a large cohort of veterans. They also reported several prospective drugs for FDA clinical trials. As a result of the survey data and other extensive studies, CBIS said they now have the data necessary their first application for a PTSD drug for FDA clinical trials; the Company plans to hire a group of FDA specialists to handle their first FDA filings.
March 4, 2010
CBIS announced that it has set its second FDA drug target on the $20 Billion "Chronic Pain" market and plan to launch a new survey of cannabis use by chronic pain patients to gather additional first hand information from all chronic pain suffers. You can find a list of drug targets on the CBIS website.
May 24, 2010
CBIS acquired 100% of a private company with two revenue producing operations, an organic medical cannabis growing facility and a medical cannabis dispensary for patients in Colorado in accordance with state laws. This added income provides CBIS with a revenue stream much sooner than otherwise possible and they plan to expand them by acquiring a larger facility which will enhance their ability to develop pharmaceutical cannabis products for FDA approval. The company issued 2.4 million shares to pay for the acquisition of the operations and as compensation for a management contract. Currently, there are 64,570,574 shares outstanding and management expects to retire most of its debt by the end of June 2010 to eliminate a major source of risk. The former owner, Mr. Adam Pasquale, is joining the CBIS as Director of Horticulture with responsibility for managing these operations and the implementation of CBIS’s plan to expand these areas nationally, as the laws allow. As of July 21, 2010, they still have 64,570,574 shares outstanding.
June 1, 2010
Dr. Robert Melamede said that CBIS is negotiating the purchase of a privately held biopharmaceutical company that owns complementary patented intellectual property for specific clinical stage cannabinoid products and uses. He went on to say that they filed a preliminary patent disclosure with the University of Colorado regarding the additional new technology they intend to develop through the targeted private company acquisitions and plan to hire a patent attorney to help with the University disclosure and ultimate patent filings. Additionally, they are working with FDA consultants in their quest to obtain FDA approval for several new pharmaceutical products they believe can be derived from this deal. Dr. Melamede said efforts to identify and consolidate various new technologies aimed at developing pharmaceutical cannabis products for critical illnesses and worldwide distribution would continue.
June 28, 2010
CBIS said they viewed UK-based GW Pharmaceuticals receipt of a $15 million milestone payment from Bayer as an important signpost for the continued validation of medical cannabis. According to the press release, the payment to GW was based on the UK Government's approval of GW Pharmaceuticals Sativex(R), an "Oromucosal Spray" tincture for the treatment of spasticity due to Multiple Sclerosis (MS) and is the first cannabis drug to be approved in the UK. According to Piper Jaffary analysts, peak sales for Sativex(R) could reach $180 million in Europe and Canada combined. The release mentioned that the US FDA previously granted GW a Phase III IND for Sativex, and a Phase IIb/III trial for cancer pain, GW’s receipt of an 18 million dollar licensing fee from Otsuka for the US rights and the receipt of several million from licensing fees from Almiral of Spain for the European rights outside of the UK which included payment for the work necessary to obtain regulatory approval. In a nutshell, it appears that Big Pharma has recognized the potential of this industry and wants a piece of the action. Additionally, the approval sativex(R) by the FDA could potentially lead to the fast-tracking of other whole cannabis extracts.
June 29, 2010
Dr. Robert Melamede PhD, President and CEO of CBIS, said that the expansion of the internal production of CBIS at their Montana Pain Management (MPM) facility would allow them to expand their patient base by 100 new clients each month and help advance their objectives in developing pharmaceutical applications for medical CBIS. He further stated that the coupling of the internal production facility, MPM’s agricultural staff and CBIS’s scientists and commercial production staff aggressively positions CBIS to be a key player in the developing national medical CBIS industry. The release also mentioned that Montana officials were working with Rick Rosio, President and CEO of MPM, to develop policies that protect patients and help them access the medicines they need. An early June press release announced the acquisition of MPM by CBIS in June 2010.
July 8, 2010
CBIS announced their execution of a long-term lease on a 9,500 square foot facility in Denver, Colorado, that will become its corporate offices, as well as serving as a research facility for developing, testing, and production in compliance with the new Colorado laws regulating medical marijuana in the state. What intrigued me was the mention of the “long-term” lease.
According to the CBIS website, several states have already approved cannabis for medicinal approval. From all indications, California is well on their way to approving Proposition 19. If it passes in California and has a positive impact on their troubled economic condition, I wonder how many other troubled states would follow suit? If it does, it appears as though CBIS is doing everything possible to hit the ground running when the time comes" (http://seekingalpha.com/instablog/457722-la-stock-talk/82971-cannabis-science-inc-otcbb-cbis?source=new_post).
Master manipulation to start the day as well :(
20100721|CBIS|627788|1030386|O 60.93%
The .08's are about to get burneeeedd
Sure is quiet over here for the day we have been waiting for...
CBIS, I warned you.
Time to dust off the ole moon shoes.
CBIS EXPLOSION!!
Today is looking HOT so far!!
lol, my CBIS boat is starting to look like Noah's Ark.
Ya things are looking really good imo. Its starting to snowball!
Big buys coming through at the ask, this boat may be turning around!
Nice buying volume to start the day!
Good post! The 8K in late August is going to be huge imo.
Not yet, I left a message today though, I am sure I will hear back from him soon. Acquisition news is also always possible.
20100720|CBIS|206607|266100|O 77.64%
Man this stock trades weird...almost all buys for the day while we go down and have this large of a short percent...
Still appears to be no shorting today. Good stuff. A good PR (which I know they have some in the works) and we are taking off.